[Placental circulation in simultaneous beta-stimulation using hexoprenaline and beta-1 blockade with celiprolol].
In a therapy with Hexoprenalin 0.3 microgram/min an additional administration of Celiprolol (3 X 100 micrograms oral) or Placebo did not change significantly the Placenta perfusion. It remains a question, if an additional therapy with beta 1-mimetic agents is necessary, since Hexoprenalin alone did not change the cardiovascular parameters significantly. This results are not transferable to altered dose or to different betamimetic- and beta blocking agents.
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D017272:Celiprolol; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006594:Hexoprenaline / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D008431:Maternal-Fetal Exchange / Q000187:drug effects*; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D010627:Phenethylamines / Q000627:therapeutic use*; D010920:Placenta / Q000098:blood supply*; D011247:Pregnancy; D011412:Propanolamines / Q000627:therapeutic use*; D012039:Regional Blood Flow / Q000187:drug effects; D014590:Uterine Contraction / Q000187:drug effects
D010627:Phenethylamines; D011412:Propanolamines; D017272:Celiprolol; D006594:Hexoprenaline
Die Plazentadurchströmung bei simultaner beta-Stimulation mit Hexoprenalin und beta 1-Blockade mit Celiprolol.